DIN 02480522 — XYDALBA 500 MG
XYDALBA is a powder for solution of Dalbavancin marketed by KNIGHT THERAPEUTICS INC.. The full Dalbavancin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02480522
- Brand name
- XYDALBA
- Active ingredient
- Dalbavancin
- Strength
- 500 MG
- Dosage form
- POWDER FOR SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- KNIGHT THERAPEUTICS INC.
- Health Canada status
- MARKETED
- Drug class
- Lipoglycopeptide antibacterial agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.